Sarcoma, Clear Cell
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue (NCT04593758) | Cornerstone Pharmaceuticals | 2021-09-01 |
| Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma (NCT00258687) | Dana-Farber Cancer Institute | 2005-01-01 |
Track Sarcoma, Clear Cell automatically
Every clearance here is in the API, with alerts when new ones post.